rct
    2018
    High Quality

    n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease (DREAM)

    Asbell PA, Maguire MG, Pistilli M

    Published in New England Journal of Medicine

    Methodology

    Multicentre double-blind RCT of 3000 mg/day EPA+DHA versus olive oil placebo for 12 months in moderate-to-severe dry eye.

    Key Findings

    No significant difference in symptom score improvement between omega-3 and placebo (change 13.9 vs 12.5 points); signs also unchanged.

    Conclusions

    High-dose omega-3 did not relieve dry eye symptoms or visual disturbance beyond placebo.

    Limitations

    Placebo was olive oil, which may not be inert; high adherence population.

    Supplements Studied

    High-dose omega-3 did not relieve dry eye symptoms beyond placebo.

    Outcomes Measured

    Omega-3 did not improve dry eye symptoms or signs versus placebo.

    Related Health Concerns

    Study Details

    Year:2018
    Sample Size:535
    Quality Score:9/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.